Navigation Links
GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
Date:2/14/2008

GenOdyssee has Received Notice of Allowance of United States Patent Application Covering its Lead HCV Interferon-alpha Product GEA007.1, a

Natural Protein With Improved Anti-HCV Genotype 1 Activity

PARIS, France, February 14 /PRNewswire/ -- GenOdyssee S.A., a biotechnology company dedicated to the discovery and development of improved 'next generation' blockbuster protein therapeutic products, announced today that it has received notice of allowance from the United States Patent and Trademark Office (USPTO) of its Patent Application Ndegrees 10/691,653 covering its lead anti-HCV IFN-alpha product GEA007.1 for application in the treatment of hepatitis C. GEA007.1 is a naturally occurring mutant of human IFN alpha 17. In preclinical studies, GEA007.1 demonstrated improved intrinsic anti-genotype 1 antiviral properties without increased toxicity at therapeutic doses used in HCV treatments, as compared to standard of care IFN-alpha 2 drugs.

"We are very happy with this notice of allowance, which represents an important milestone for us. Combined with the granting in the European Union in 2006 of our patent application covering GEA007.1, this is a proof-of-concept of the global standard of innovation set by our lead HCV program," said Jean-Louis Escary, Ph.D., CEO of GenOdyssee. Similar to the European Patent Office notice of allowance report on this product that was issued in 2006, the current USPTO notice of allowance report did not reveal any prior art references relevant to the invention constituted by GEA007.1.

A recent communication with the USPTO revealed that GenOdyssee's patent application covering a second lead IFN-alpha drug candidate, GEA009.2, to be used in cancer, is expected to be allowed in the United States in the near future. "This confirms the uniqueness of GenOdyssee's proprietary technology as well as our global leadership position in the interferon arena," said Dr. Escary. "Our technology has also proven to
'/>"/>

SOURCE GenOdyssee SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Quintiles Central Laboratory in India Receives CAP Certification
2. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
3. Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs
4. Stereotaxis Receives $20 Million in Additional Loan Commitments
5. MedApps Receives Prestigious Frost & Sullivan Award
6. IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
7. Ludwig Institute for Cancer Research receives NHMRCs largest 2009 grant
8. Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program
9. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
10. Regions Hospital Receives National Quality Awards
11. Laser Energetics Receives a $550,000 Order for a Dental Laser System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., LOS ANGELES, Nov. 30 A ne...ert Wood Johnson Foundation Center for Health Poli...r), and impreMedia, shows a widespread consensus a...tance of health care reform and indicates signific...st time, health care tops the list of national iss...
(Date:11/30/2009)...NEAPOLIS, Nov. 30 The Eject Helmet... required equipment in the Top Fuel, Funny Car, Pr...e National Hot Rod Association (NHRA) Full Throttl...ragster and Top Alcohol Funny Car drivers in the N...nly product that allows medical caregivers at race...
(Date:11/30/2009)... Keynote speaker & Author Dr. Temple Grandi... Corpus Christi, TX (Vocus) November 30, ... is set to be held in Corpus Christi from Thursday... the American Bank Center., , , , ,The conference...e a nearly $300,000 economic impact on the city. T...
(Date:11/30/2009)..., N.J., Nov. 30 Kemin Foods, L.C. ... and OmniActive Health Technologies, Ltd. ("OmniAc...r dispute. The parties agree that Kemin,s US Paten...s for Isolation, Purification and Recrystallizatio... Uses Thereof" and the reissues of that patent are...
(Date:11/30/2009)...R, N.J., Nov. 30 Advanced Health M...ing logistics, speaker programs and commercial com...industry, announced it has been named the second f...Jersey,s leading statewide business newspaper. AH...hat have made significant contributions to the sta...
Breaking Medicine News(10 mins):Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2
...tor without license has been impersonating as a li...dical tests on immigrants, providing them with fal...apped 106 felonies after his guilt was established...f vaccines. He had also extracted blood to check f...
...ing cause of blindness, worldwide would affect 60 ...end of 2020, // based on a projection in the Briti...ifically Indians and Africa would be the worst aff...er would be women as per the 2010 prediction. ...
...backseat as youngsters in Pakistan celebrated Vale... the media too joined in by hosting special progra...kistani cricket teams arrived here for the fourth ...There was no dearth of shops in the city selling V...
...say that they have formulated a combination of dru... believed for a long time that new borns did not f... rest by stringent research. The problem was how t... complex issue. Taddio, a scientist and pharmacolo...
... in the air now that if it weren't for our lungs t.../ The order of the French President Jacques ... carrier Clemenceau to be sent back to France, rep... the proposed transfer of the ship that is laden w...
... All marks to the efforts of a pilot study, which ...the precincts // of one’s home or a General Pract...ul results, according to report announcements. ...ting. 172 women underwent abortions as part o...
Other Medicine News:Health News:Valentine's Day Theme Overshadows Cricket in Pakistan 2Health News:The Return Of The Clemenceau: Happy India 2
(Date:11/30/2009)..., , SCOTTSDALE, Ariz., Nov. 30 /PRNews...he leading provider of radiology solutions to radi...tates, has implemented a redesigned Quality Assura...tween NightHawk,s radiologists and customers and t... will be providing an overview of the new QA progr...
(Date:11/30/2009)..., , MT. LAUREL, N.J., Nov. 30 /PRNewswire... leading provider of technology-enabled clinical d... this week at the Radiological Society of North Am...Q VTB for Radiology, the product leverages Speec... recognition application used by thousands of radi...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ -...earch report is available in its catalogue: ,, ...e ,, http://www.reportlinker.com/p0164347/Dia...ml ,, Diabetes Diagnosis market is driven by ...d with diabetes, both in the developed and develop...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Risks involved with transgenic fish 9742 1Risks involved with transgenic fish 9742 2Clemson research nets 242 million from NSF to mimic natures probes 9738 1Clemson research nets 242 million from NSF to mimic natures probes 9738 2ClariVein 28TM 29 Catheter for Varicose Veins 3A Clinical Trial Results to be Presented 4922 1ClariVein 28TM 29 Catheter for Varicose Veins 3A Clinical Trial Results to be Presented 4922 2
...of market dynamics offers insights into,what will ...o,patients, NEW YORK, May 14, 2007 /PRNewswire-USN...ment (TB Alliance), a not-for-profit,product deve...,development of new TB drugs, today released resul...ics of the global TB drug market,that offers a det...
...-May 15, 2007 - Gemin X Biotechnologies,Inc. annou...Blood,demonstrated that its lead compound, obatocl...le Cell Lymphoma (MCL) cell lines and,primary cell...small,molecule specifically designed to inhibit al...validated cancer target, thus restoring,the natura...
Other Medicine Technology:New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...utostat™II Rheumatoid Factor IgM enzyme linked...id Factor IgM (RF IgM). Enzyme-linked immunosorben...of specific IgM Rheumatoid Factor in human serum. ...aid in the diagnosis of Rheumatoid Arthritis when ...
ACUVUE OASYS with HYDRACLEAR™ PLUS
Carriazo-Pendular
...ctor I or somatomedin-C, is a peptide highly depen...ting activity. IGF-I is transported in serum by se...owth disorders, measurements of IGF-I are a useful.... A normal plasma or serum IGF-I concentration is ...
Medicine Products: